杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/11/07 | 1,428 | 1,433 | 1,409 | 1,412 | -13 | -0.9% | 130,000 |
2011/11/04 | 1,435 | 1,442 | 1,422 | 1,425 | +16 | +1.1% | 115,000 |
2011/11/02 | 1,414 | 1,431 | 1,401 | 1,409 | -14 | -1% | 100,000 |
2011/11/01 | 1,428 | 1,443 | 1,423 | 1,423 | -30 | -2.1% | 103,000 |
2011/10/31 | 1,452 | 1,493 | 1,450 | 1,453 | -16 | -1.1% | 152,000 |
2011/10/28 | 1,474 | 1,489 | 1,454 | 1,469 | +17 | +1.2% | 296,000 |
2011/10/27 | 1,438 | 1,488 | 1,438 | 1,452 | +5 | +0.3% | 205,000 |
2011/10/26 | 1,432 | 1,462 | 1,407 | 1,447 | +22 | +1.5% | 184,000 |
2011/10/25 | 1,450 | 1,454 | 1,419 | 1,425 | -40 | -2.7% | 225,000 |
2011/10/24 | 1,477 | 1,480 | 1,464 | 1,465 | -17 | -1.1% | 108,000 |
2011/10/21 | 1,492 | 1,492 | 1,473 | 1,482 | -14 | -0.9% | 62,000 |
2011/10/20 | 1,480 | 1,512 | 1,476 | 1,496 | +20 | +1.4% | 212,000 |
2011/10/19 | 1,473 | 1,484 | 1,469 | 1,476 | +21 | +1.4% | 76,000 |
2011/10/18 | 1,447 | 1,462 | 1,447 | 1,455 | -10 | -0.7% | 41,000 |
2011/10/17 | 1,478 | 1,487 | 1,464 | 1,465 | +13 | +0.9% | 74,000 |
2011/10/14 | 1,446 | 1,460 | 1,439 | 1,452 | -10 | -0.7% | 162,000 |
2011/10/13 | 1,477 | 1,482 | 1,461 | 1,462 | -16 | -1.1% | 150,000 |
2011/10/12 | 1,481 | 1,501 | 1,464 | 1,478 | -22 | -1.5% | 175,000 |
2011/10/11 | 1,503 | 1,537 | 1,480 | 1,500 | -2 | -0.1% | 215,000 |
2011/10/07 | 1,526 | 1,542 | 1,501 | 1,502 | -12 | -0.8% | 167,000 |
2011/10/06 | 1,513 | 1,521 | 1,497 | 1,514 | -7 | -0.5% | 90,000 |
2011/10/05 | 1,577 | 1,577 | 1,508 | 1,521 | -68 | -4.3% | 258,000 |
2011/10/04 | 1,604 | 1,618 | 1,586 | 1,589 | -34 | -2.1% | 160,000 |
2011/10/03 | 1,606 | 1,629 | 1,587 | 1,623 | +5 | +0.3% | 126,000 |
2011/09/30 | 1,629 | 1,634 | 1,593 | 1,618 | -12 | -0.7% | 204,000 |
2011/09/29 | 1,607 | 1,638 | 1,599 | 1,630 | +23 | +1.4% | 159,000 |
2011/09/28 | 1,589 | 1,621 | 1,589 | 1,607 | +22 | +1.4% | 164,000 |
2011/09/27 | 1,576 | 1,593 | 1,571 | 1,585 | +17 | +1.1% | 142,000 |
2011/09/26 | 1,545 | 1,595 | 1,545 | 1,568 | +30 | +2% | 279,000 |
2011/09/22 | 1,560 | 1,560 | 1,530 | 1,538 | -21 | -1.3% | 243,000 |
2011/09/21 | 1,571 | 1,576 | 1,555 | 1,559 | -2 | -0.1% | 96,000 |
2011/09/20 | 1,571 | 1,591 | 1,556 | 1,561 | -35 | -2.2% | 200,000 |
2011/09/16 | 1,605 | 1,612 | 1,586 | 1,596 | -12 | -0.7% | 163,000 |
2011/09/15 | 1,607 | 1,619 | 1,600 | 1,608 | +1 | +0.1% | 118,000 |
2011/09/14 | 1,591 | 1,619 | 1,583 | 1,607 | -3 | -0.2% | 246,000 |
2011/09/13 | 1,593 | 1,616 | 1,584 | 1,610 | +40 | +2.5% | 297,000 |
2011/09/12 | 1,551 | 1,572 | 1,548 | 1,570 | +2 | +0.1% | 126,000 |
2011/09/09 | 1,563 | 1,585 | 1,563 | 1,568 | +11 | +0.7% | 156,000 |
2011/09/08 | 1,548 | 1,560 | 1,541 | 1,557 | +9 | +0.6% | 87,000 |
2011/09/07 | 1,544 | 1,558 | 1,544 | 1,548 | +6 | +0.4% | 162,000 |
2011/09/06 | 1,548 | 1,562 | 1,542 | 1,542 | -5 | -0.3% | 159,000 |
2011/09/05 | 1,537 | 1,556 | 1,537 | 1,547 | -8 | -0.5% | 68,000 |
2011/09/02 | 1,565 | 1,577 | 1,545 | 1,555 | +9 | +0.6% | 240,000 |
2011/09/01 | 1,561 | 1,570 | 1,536 | 1,546 | -2 | -0.1% | 160,000 |
2011/08/31 | 1,525 | 1,599 | 1,525 | 1,548 | +32 | +2.1% | 269,000 |
2011/08/30 | 1,526 | 1,537 | 1,502 | 1,516 | +2 | +0.1% | 295,000 |
2011/08/29 | 1,462 | 1,535 | 1,462 | 1,514 | -12 | -0.8% | 333,000 |
2011/08/26 | 1,523 | 1,538 | 1,519 | 1,526 | -8 | -0.5% | 117,000 |
2011/08/25 | 1,541 | 1,551 | 1,530 | 1,534 | -11 | -0.7% | 133,000 |
2011/08/24 | 1,568 | 1,568 | 1,538 | 1,545 | -28 | -1.8% | 247,000 |
3301~
3350
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,000円 | +8.8% | +99.9% | 3.54% | 9.38倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 231,800円 | +21.7% | +999.9% | 0.00% | 9.65倍 | 3.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 307,000円 | +3.0% | +27.5% | 2.61% | 19.44倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 221,000円 | +0.4% | -8.4% | 2.40% | 28.37倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 90,100円 | +20.3% | - | 0.00% | 158.91倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム